Rapid progression of acquired amegakaryocytic thrombocytopenia to myelodysplastic syndrome: Case report

Turkish Journal of Haematology

Volumn 22, Issue 4, 2005, Pages 205-208

  Erkurt, Mehmet Ali ^a   Kaya, Emin ^a   Baran, Murat ^a   Yitmen, Ece ^a   Şenel, Soner ^a   Kuku, Irfan ^a   Aydoǧdu, Ismet ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acquired amegakaryocytic thrombocytopenia; Myelodysplastic syndrome

Indexed keywords

CYCLOSPORIN; DANAZOL; HEMOGLOBIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BONE MARROW BIOPSY; BRAIN HEMORRHAGE; CASE REPORT; DEATH; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; FEMALE; GINGIVA BLEEDING; HEMATOCRIT; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEGAKARYOCYTE; MUCOSAL BLEEDING; MYELODYSPLASTIC SYNDROME; RETICULOCYTE COUNT; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 33144462959     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gewirtz AM, Hoffman R. Human megakaryocyte production: cell biology and clinical considerations. Hematol Oncol Clin North Am 1990;4:43-64.
2. Gewirtz AM, Hoffman R. Primary platelet production disorders. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al (eds). Hematology: Basic Principles and Practice. New York: Churchill-Livingstone, 1991:205-10.
3. George JN, Aster RH. Thrombocytopenia due to diminished or defective platelet production. In: Williams WJ, Beutler E, Ersler AJ, Lichtman NA (eds). Haematology. 4th ed. New York: Hill Publishing Co; 1991;1343-13451.
4. Stoll DB, Blum S, Pasquale D. Thrombocytopenia with decreased megakaryocytes. Ann Intern Med 1981;94:170-5.
5. Griner PH, Hoyer LW. Amegakaryocytic thrombocytopenia in systemic lupus erythematosus. Arch Int Med 1970;125:328-32.
6. Nagasawa T, Sakurai T, Kashiwagi H, Abe T. Cell-mediated amegakaryocytic thrombocytopenia associated with systemic lupus erythematosus. Blood 1986;67:479-83.
7. Sakurai T, Kono I, Kabashima T. Amegakaryocytic thrombocytopenia associated with SLE successfully treated by a high-dose prednisolone therapy. Jpn J Med 1984;23:136-8.
8. Ghos K, Sarode R, Verma N. Amegakaryocytic thrombocytopenia of nutritional vitamin B12 deficiency. Trop Geogr Med 1988;40:158-60.
9. Felderbauer P, Ritter PR, Mattern D, Schmitz F, Bulut K, Ansorge N, Schmitt-Graeff A, Schmidt WE, Baier JE. Acquired pure megakaryocytic aplasia: a separate haematological disease entity or a syndrome with multiple causes. Eur J Haematol 2004;72:451-4.
10. Benedetti F, de Sabata D, Perona G. T suppressor activated lymphocytes (CD8+/DR+) inhibit megakaryocyte progenitor cell differentiation in a case of acquired amegakaryocytic thrombocytopenic purpura. Stem Cells 1994;12:205-13.
11. Kurvaki T, Hagiwara T, Kafo T, et al. Presence of autoantibodies that can neutralize the biological activity of thrombopoietin in a patient with amegakaryocytic thrombocytopenic purpura. Blood 1998;92: 472a.
12. Trimble MS, Glynn MF, Brain MC. Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin. Am J Hematol 1991;37:126-7.
13. Hoffman R, Bruno E, Elwell J, Mazur E, Gewirtz AM, Dekker P, Denes A, et al. Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies. Blood 1982;60:1173-8.
14. Harjai K, Shah M, Pant A, Kale P, Pathare AV. Amegakaryocytic thrombocytopenic purpura. J Postgrad Med 1992;38:96-7.
15. Hill W, Landgraf R. Successful treatment of amegakaryocytic thrombocytopenic purpura with cyclosporine. N Engl J Med 1985;312:1060-1.
16. Kashyap R, Choudhry VP, Pati HP. Danazol therapy in cyclic acquired amegakaryocytic thrombocytopenic purpura: a case report; Am J Hematol 1999;60:225-8.